Anna Viola - Concepedia

Author

Anna Viola

Also Known As

A Viola, A. M. Viola, A. Viola, ANNA VIOLA, Anna M. Viola, Anna Maria Viola, Anna VIOLA, Anna Viola, Antonietta Viola, Serena Porcari

177

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University of Messina Ospedale Vincenzo Cervello Ospedale Cannizzaro Istituti di Ricovero e Cura a Carattere Scientifico University of Padua

About

Anna Viola is an author at University of Messina specializing in medicine, molecular biology, and molecular genetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	220
2	Natural Sciences	3	3	46
3	Health Sciences	1	1	32
4	Social Sciences	1	1	15
5	Biochemistry	1	1	19

Anna Viola

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Dual Targeted Therapy: A Possible Option for the Management of Refractory Inflammatory Bowel Disease Giuseppe Privitera, Sara Onali, Daniela Pugliese, Journal of Crohn s and Colitis	2020	81
Ultrasonography Tight Control and Monitoring in Crohn’s Disease During Different Biological Therapies: A Multicenter Study Emma Calabrese, Antonio Rispo, Francesca Zorzi, Clinical Gastroenterology and Hepatology	2021	78
Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT) Barbara Alicja Jereczek‐Fossa, Damaris Patricia Rojas, Dario Zerini, British Journal of Radiology	2018	70
Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case–Control IG-IBD Study Livia Biancone, Alessandro Armuzzi, Maria Lia Scribano, Inflammatory Bowel Diseases	2019	65
Impressive Results after “Metabolism-Guided” Lattice Irradiation in Patients Submitted to Palliative Radiation Therapy: Preliminary Results of LATTICE_01 Multicenter Study Gianluca Ferini, Silvana Parisi, Sara Lillo, Cancers	2022	58
An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors Sara Onali, Daniela Pugliese, Flavio Caprioli, The American Journal of Gastroenterology	2022	46
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab Agnese Favale, Sara Onali, Flavio Caprioli, Inflammatory Bowel Diseases	2019	44
The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches Fabio Salvatore Macaluso, Walter Fries, Anna Viola, Inflammatory Bowel Diseases	2020	44
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the <scp>IG‐IBD LIVE</scp> study Daniela Pugliese, Giuseppe Privitera, Federica Crispino, Alimentary Pharmacology & Therapeutics	2022	43
Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD “AGED study” Walter Fries, Anna Viola, Natalia Manetti, Digestive and Liver Disease Chronic Inflammatory DiseasesMucosal ImmunologyGastroenterologyPathologyLate-onset Ulcerative Colitis	2016	41

Page 1